Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
112.50    3.50 (3.23%)
Bid:
110.00
Ask:
115.00
Spread: 5.00 (4.545%)
Market Cap: £67.38m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

11 Apr 2008 07:00

Intercede Group PLC11 April 2008 11 APRIL 2008 INTERCEDE GROUP PLC ("Intercede" or "the Company") Trading Update for the Full Year to 31 March 2008 On 14 February 2008, Intercede announced a number of new contract wins, andfurther progress on several existing projects. As it enters its closed periodahead of announcing full year results for the financial year ended 31 March2008, Intercede is pleased to report that it continues to experience high levelsof interest in and demand for its MyID technology. Good progress has been made with all of the projects referred to in theCompany's previous announcement. Intercede has also been engaged with a numberof new prospects. To put this in perspective, the Group is currently involved insignificant work on over 10 major projects whereas, as recently as 2 years ago,Intercede was typically only working on 2 major projects at a time. The momentumis therefore clearly building and we are increasingly confident that this willbe reflected in future financial performance as more and more projects movebeyond the initial POC and pilot phases. Significant progress has also been made during the past year with thedevelopment of MyID Version 8.0 which is scheduled for launch during the currentquarter. MyID Version 8.0 represents a substantial strengthening and broadeningof the Group's historical card management offering since it is the only solutionof its kind to deliver registration, ID verification and card/device issuanceand life cycle management within a single product. Pre audit indications of the results for the year ended 31 March 2008 are thatrevenues have increased from £2.6m to £2.8m. Costs continue to be tightlycontrolled and have been maintained at the same level as the prior yearresulting in a substantial reduction in last year's operating loss of £0.3m.Year end cash balances totalled £1.15m. Intercede expects to announce its full year results for the year ended 31 March2008 by early June 2008. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). Intercede's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates, Open Platform appletsand physical access control systems. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology to the global market place including:Athena Smartcard Solutions, Gemalto, Oberthur Card Systems, Oracle, RSASecurity, SafeNet, Thales, VeriSign and a variety of systems integrators andother security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. For more information visit http://www.intercede.com ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director KBC Peel Hunt Tel. +44 (0)20 7418 8900Richard KaufferDaniel Harris Pelham Public RelationsArchie Berens Tel. +44 (0)20 7743 6679 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.